Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Berezhnoy, Dmytro, Gravielle, Maria C, Downing, Scott, Kostakis, Emmanuel, Basile, Anthony S, Skolnick, Phil, Gibbs, Terrell T, Farb, David H
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2529273/
https://ncbi.nlm.nih.gov/pubmed/18554397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-8-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars